1. Home
  2. STVN vs BBU Comparison

STVN vs BBU Comparison

Compare STVN & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$17.50

Market Cap

3.7B

ML Signal

HOLD

Logo Brookfield Business Partners L.P. Limited Partnership Units

BBU

Brookfield Business Partners L.P. Limited Partnership Units

HOLD

Current Price

$31.46

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STVN
BBU
Founded
1949
2016
Country
Italy
Bermuda
Employees
N/A
N/A
Industry
Containers/Packaging
Engineering & Construction
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.1B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
STVN
BBU
Price
$17.50
$31.46
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$25.67
$39.40
AVG Volume (30 Days)
500.4K
149.9K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
0.39%
0.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.67
N/A
Revenue Next Year
$9.99
N/A
P/E Ratio
$27.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.89
$23.31
52 Week High
$28.00
$37.75

Technical Indicators

Market Signals
Indicator
STVN
BBU
Relative Strength Index (RSI) 56.51 44.87
Support Level $13.58 $29.90
Resistance Level $19.05 $36.93
Average True Range (ATR) 0.78 1.38
MACD -0.10 0.23
Stochastic Oscillator 40.84 46.92

Price Performance

Historical Comparison
STVN
BBU

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

Share on Social Networks: